ethylnitrosourea has been researched along with Dysmyelopoietic Syndromes in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chatterjee, R; Gupta, S; Law, S | 1 |
Abdel-Wahab, O; Bradley, RK; Durham, B; Fei, DL; Ferrarone, J; Garrett, L; Liu, P; Varmus, H; Yoshimi, A; Zhang, T; Zhen, T | 1 |
Chaudhuri, S; Das, M; Law, S | 1 |
Ding, L; DiPersio, JF; Fulton, R; Graubert, TA; Ley, TJ; Link, DC; Lu, EP; Mardis, ER; McLellan, M; Miller, CA; Walter, MJ; Westervelt, P; Wilson, RK | 1 |
Gratzinger, D; Johnson, C; Jonas, BA; Majeti, R | 1 |
5 other study(ies) available for ethylnitrosourea and Dysmyelopoietic Syndromes
Article | Year |
---|---|
Hematopathological alterations of major tumor suppressor cascade, vital cell cycle inhibitors and hematopoietic niche components in experimental myelodysplasia.
Topics: Animals; Cell Cycle; Disease Models, Animal; Ethylnitrosourea; Female; Glycogen Synthase Kinase 3 beta; Hematopoietic Stem Cells; Male; Membrane Potential, Mitochondrial; Mice; Myelodysplastic Syndromes; Stem Cell Niche; Tumor Suppressor Proteins | 2017 |
Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene
Topics: Alleles; Animals; Core Binding Factor Alpha 2 Subunit; Ethylnitrosourea; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Hematopoiesis; Humans; Leukemia; Mice; Mice, Transgenic; Mutation; Myelodysplastic Syndromes; RNA Splicing; Splicing Factor U2AF | 2018 |
Unveiling the paradoxical nature of myelodysplastic syndromes (MDS): why hypercellular marrow strongly favors accelerated apoptosis.
Topics: Anemia, Aplastic; Animals; Apoptosis; Bone Marrow Cells; Bone Marrow Diseases; Bone Marrow Failure Disorders; Caspase 3; Cell Cycle; Cell Proliferation; Cell Survival; Ethylnitrosourea; fas Receptor; Female; Hemoglobinuria, Paroxysmal; HSP70 Heat-Shock Proteins; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase Kinase 5; Mice; Myelodysplastic Syndromes; Telomerase; Telomere Shortening; Tumor Suppressor Protein p53 | 2013 |
Caspase-9 is required for normal hematopoietic development and protection from alkylator-induced DNA damage in mice.
Topics: Alkylating Agents; Animals; Apoptosis; Bone Marrow; Bone Marrow Cells; Caspase 9; Crosses, Genetic; DNA Damage; Ethylnitrosourea; Flow Cytometry; Gene Expression Regulation, Developmental; Hematopoiesis; Hematopoietic Stem Cells; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Myelodysplastic Syndromes; Phenotype | 2014 |
Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations with Leukemia Stem Cell Activity.
Topics: Alkylating Agents; Animals; Bone Marrow Cells; Disease Models, Animal; Ethylnitrosourea; Humans; Leukemia, Myeloid, Acute; Mice; Myelodysplastic Syndromes; Neoplasms, Second Primary; Neoplastic Stem Cells | 2016 |